Revenue
2020
2021
2022
2023
2024
2025
Sight Sciences, Inc. (SGHT)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $77.4M | $79.9M | $81.1M | $71.3M | $49.0M | $27.6M |
| Gross profit | $66.7M | $68.3M | $69.2M | $59.0M | $40.3M | $18.4M |
| Research & development | $14.6M | $18.0M | $17.6M | $22.9M | $15.6M | $8.9M |
| Operating expenses | $103.8M | $118.8M | $126.4M | $142.9M | $91.8M | $50.6M |
| Operating income | −$37.1M | −$50.5M | −$57.3M | −$84.0M | −$51.5M | −$32.2M |
| EBITDAderived | −$36.6M | −$49.8M | −$56.7M | — | — | — |
| Net income | −$38.4M | −$51.5M | −$55.5M | −$86.2M | −$63.0M | −$34.7M |
| Basic EPSper diluted share | -$0.74 | -$1.03 | -$1.14 | -$1.80 | -$2.36 | -$3.71 |
| Diluted EPSper diluted share | -$0.74 | -$1.03 | -$1.14 | -$1.80 | -$2.36 | -$3.71 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 10, 2026Form 4 | Encrantz StaffanDirector,TenPercentOwner | BuyCommon Stock | 14.1K | $4.88 | $68.8K | 1.43M |
| May 18, 2026Form 4 · 10b5-1 | Bauerlein AlisonChief Operating Officer | SellCommon Stock | 12.7K | $5.12 | $65.2K | 688.9K |
| Apr 6, 2026Form 4 · 10b5-1 | Rodberg JamesChief Financial Officer | SellCommon Stock | 7.2K | $3.55 | $25.7K | 230.9K |
| Apr 6, 2026Form 4 · 10b5-1 | HAYDEN JEREMY B.Chief Legal Officer | SellCommon Stock | 13.8K | $3.55 | $48.9K | 369.8K |
| Apr 2, 2026Form 4 · 10b5-1 | Bauerlein AlisonChief Operating Officer | SellCommon Stock | 25.9K | $3.48 | $90.0K | 701.6K |